[1]
“Efficacy and Safety of Gabapentine and Duloxetine in Diabetic Peripheral Neuropathic Pain”, Med. Today, vol. 33, no. 2, pp. 108–113, Nov. 2021, doi: 10.3329/medtoday.v33i2.56054.